Sepsis en pediatría

1 Bone RC. The sepsis syndrome. Definition and general approach to management. Clin Chest Med 1996; 17:175-81.
2 Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348:138-50.
3 Goldstein B, Giroir B, Randolph A; International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 2005; 6:2-8.
4 World Health Organization Global Health Observatory. Causes of child mortality. 2013. www.who.int/gho/child_health/mortality/causes/en/
5 Vincent JL, Opal SM, Marshall JC, et al. Sepsis definitions: time for change. Lancet 2013; 381:774-5.
6 World Health Organization. The World Health report 1996—fighting disease, fostering development. May 1996. www.who.int/whr/1996/en/.
7 Watson RS, Carcillo JA, Linde-Zwirble WT, et al. The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med 2003; 167:695-701.
8 Hartman ME, Linde-Zwirble WT, Angus DC, et al. Trends in the epidemiology of pediatric severe sepsis. Pediatr Crit Care Med 2013; 14:686-93.
9 Ruth A, McCracken CE, Fortenberry JD, et al. Pediatric severe sepsis: current trends and outcomes from the Pediatric Health Information Systems database. Pediatr Crit Care Med 2014; 15:828-38.
10 Weiss SL, Fitzgerald JC, Pappachan J, et al. Global epidemiology of pediatric severe sepsis: the Sepsis Prevalence, Outcomes, and Therapies study. Am J Respir Crit Care Med 2015; published online 3 Mar.
11 Soeorg H, Huik K, Parm U, et al. Genetic relatedness of coagulase-negative Staphylococci from gastrointestinal tract and blood of preterm neonates with late-onset sepsis. Pediatr Infect Dis J 2013; 32:389-93.
12 Randolph AG, McCulloh RJ. Pediatric sepsis: important considerations for diagnosing and managing severe infections in infants, children, and adolescents. Virulence 2013; 5:8-18.
13 Lee CY, Chen PY, Huang FL, et al. Microbiologic spectrum and susceptibility pattern of clinical isolates from the pediatric intensive care unit in a single medical center—6 years’ experience. J Microbiol Immunol Infect 2009; 42:160-5.
14 Greenhow TL, Hung YY, Herz AM. Changing epidemiology of bacteremia in infants aged 1 week to 3 months. Pediatrics 2012; 129:e590-6.
15 Stoll BJ, Gordon T, Korones SB, et al. Early-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr 1996; 129:72-80.
16 Bizzarro MJ, Raskind C, Baltimore RS, et al. Seventy-five years of neonatal sepsis at Yale: 1928-2003. Pediatrics 2005; 116:595-602.
17 Posfay-Barbe KM, Wald ER. Listeriosis. Semin Fetal Neonatal Med 2009; 14:228-33.
18 Stoll BJ, Gordon T, Korones SB, et al. Late-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr 1996; 129:63-71.
19 Remick DG. Pathophysiology of sepsis. Am J Pathol 2007; 170:1435-44.
20 Levine MM, Campbell JD, Kotloff KL. Overview of vaccines and immunisation. Br Med Bull 2002; 62:1-13.
21 Department of Health. Meningococcal B vaccination programme to be introduced [press release]. 2014. https://www.gov.uk/government/news/meningococcal-b-vaccinationprogramme-to-be-introduced.
22 World Health Organization. Decade of vaccines—global vaccine action plan 2011-2020.
2015. www.who.int/immunization/global_vaccine_action_plan/DoV_GVAP_2012_2020/en/.
23 Bion J, Richardson A, Hibbert P, et al; Matching Michigan Collaboration & Writing Committee. ‘Matching Michigan’: a 2-year stepped interventional programme to minimize central venous catheter-blood stream infections in intensive care units in England. BMJ Qual Saf 2013; 22:110-23.
24 Schrag S, Gorwitz R, Fultz-Butts K, et al. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep 2002; 51:1-22.
25 Centers for Disease Control and Prevention (CDC). Perinatal group B streptococcal disease after universal screening recommendations—United States, 2003-2005. MMWR Morb Mortal Wkly Rep 2007; 56:701-5.
26 Verani JR, McGee L, Schrag SJ; Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease - revised guidelines from CDC, 2010. MMWR Recomm Rep 2010; 59:1-36.
27 Van de Wetering MD, van Woensel JB, Lawrie TA. Prophylactic antibiotics for preventing Gram positive infections associated with long-term central venous catheters in oncology patients. Cochrane Database Syst Rev 2013; 11:CD003295.
28 Weiss SL, Parker B, Bullock ME, et al. Defining pediatric sepsis by different criteria: discrepancies in populations and implications for clinical practice. Pediatr Crit Care Med 2012; 13:e219-26.
29 Vergnano S, Sharland M, Kazembe P, et al. Neonatal sepsis: an international perspective. Arch Dis Child Fetal Neonatal Ed 2005; 90:F220-4.
30 Daniels R, Nutbeam T, McNamara G, et al. The sepsis six and the severe sepsis resuscitation bundle: a prospective observational cohort study. Emerg Med J 2011; 28:507-12.
31 National Institute for Health and Care Excellence. Feverish illness in children under 5 years. (Quality standard QS64.) 2014. www.nice.org.uk/guidance/qs64.
32 Brierley J, Peters MJ. Distinct hemodynamic patterns of septic shock at presentation to pediatric intensive care. Pediatrics 2008; 122:752-9.
33 Macrae D, Grieve R, Allen E, et al. A randomized trial of hyperglycemic control in pediatric intensive care. N Engl J Med 2014; 370:107-18.
34 Polin RA; Committee on Fetus and Newborn. Management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics 2012; 129:1006-15.
35 Garcia-Prats JA, Cooper TR, Schneider VF, et al. Rapid detection of microorganisms in blood cultures of newborn infants utilizing an automated blood culture system. Pediatrics 2000; 105:523-7.
36 Levi M, Toh CH, Thachil J, et al. Guidelines for the diagnosis and management of disseminated intravascular coagulation. Br J Haematol 2009; 145:24-33.
37 Kayange N, Kamugisha E, Mwizamholya DL, et al. Predictors of positive blood culture and deaths among neonates with suspected neonatal sepsis in a tertiary hospital, Mwanza-Tanzania. BMC Pediatr 2010; 10:39.
38 Kaplan JM, Wong HR. Biomarker discovery and development in pediatric critical care medicine. Pediatr Crit Care Med 2011; 12:165-73.
39 Wong HR, Salisbury S, Xiao Q, et al. The pediatric sepsis biomarker risk model. Crit Care 2012; 16:R174.
40 Pearson GA, ed. Why children die: a pilot study 2006; England (South West, North East and West Midlands), Wales and Northern Ireland. CEMACH; 2008.
41 Parliamentary and Health Service Ombudsman. Time to act. Severe sepsis: rapid diagnosis and treatment saves lives. 2013.
www.ombudsman.org.uk/__data/assets/pdf_file/0004/ 22666/FINAL_Sepsis_Report_web.pdf.
42 Levy MM, Rhodes A, Phillips GS, et al. Surviving sepsis campaign: association between performance metrics and outcomes in a 7.5-year study. Crit Care Med 2015; 43:3-12.
43 Brierley J, Carcillo JA, Choong K, et al. Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. Crit Care Med 2009; 37:666-88.
44 Paul R, Neuman MI, Monuteaux MC, et al. Adherence to PALS Sepsis Guidelines and Hospital Length of Stay. Pediatrics 2012; 130:e273-80.
45 Inwald DP, Tasker RC, Peters MJ, et al; Paediatric Intensive Care Society Study Group (PICS-SG). Emergency management of children with severe sepsis in the United Kingdom: the results of the Paediatric Intensive Care Society sepsis audit. Arch Dis Child 2009; 94:348-53.
46 Kissoon N. Sepsis guideline implementation: benefits, pitfalls and possible solutions. Crit Care 2014; 18:207.
47 Paul R, Melendez E, Stack A, et al. Improving adherence to PALS septic shock guidelines. Pediatrics 2014; 133:e1358-66.
48 Shekerdemian L, Bohn D. Cardiovascular effects of mechanical ventilation. Arch Dis Child 1999; 80:475-480.
49 Perel P, Roberts I, Ker K. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2013; 2:CD000567.
50 Akech S, Ledermann H, Maitland K. Choice of fluids for resuscitation in children with severe infection and shock: systematic review. BMJ 2010; 341:c4416.
51 Carcillo JA. Intravenous fluid choices in critically ill children. Curr Opin Crit Care 2014; 20:396-401.
52 Goldstein SL, Somers MJG, Baum MA, et al. Pediatric patients with multi-organ dysfunction syndrome receiving continuous renal replacement therapy. Kidney Int 2005; 67:653-8.
53 Sutherland SM, Zappitelli M, Alexander SR, et al. Fluid overload and mortality in children receiving continuous renal replacement therapy: the Prospective Pediatric Continuous Renal Replacement Therapy Registry. Am J Kidney Dis 2010; 55:316-25.
54 Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34:1589-96.
55 Wang XD, Huo XM, Xu MX, et al. Clinical research of timing of application of antibiotics in septic shock of pediatric patients. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 2013; 25:207-10.
56 Weiss SL, Fitzgerald JC, Balamuth F, et al. Delayed antimicrobial therapy increases mortality and organ dysfunction duration in pediatric sepsis. Crit Care Med 2014; 42:2409-17.
57 National Institute for Health and Care Excellence. Antibiotics for early-onset neonatal infection: antibiotics for the prevention and treatment of early-onset neonatal infection. (Clinical guideline CG149) 2012. www.nice.org.uk/guidance/cg149.
58 Simmons ML, Durham SH, Carter CW. Pharmacological management of pediatric patients with sepsis. AACN Adv Crit Care 2012; 23:437-48.
59 National Institute for Health and Care Excellence. Neutropenic sepsis: prevention and management of neutropenic sepsis in cancer patients. (Clinical guideline CG151) 2012. www.nice.org.uk/guidance/cg151.
60 Dellinger RP, Levy MM, Rhodes A, et al; Surviving Sepsis Campaign Guidelines Committee. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013; 41:580-637.
61 Karam O, Tucci M, Ducruet T, et al. Red blood cell transfusion thresholds in pediatric patients with sepsis. Pediatr Crit Care Med 2011; 12:512-8.
62 Zimmerman JJ. A history of adjunctive glucocorticoid treatment for pediatric sepsis: moving
beyond steroid pulp fiction toward evidence-based medicine. Pediatr Crit Care Med 2007; 8:530-9.
63 Aneja R, Carcillo JA. What is the rationale for hydrocortisone treatment in children with infection-related adrenal insufficiency and septic shock? Arch Dis Child 2007; 92:165-9.
64 Wheeler AP, Bernard GR. Treating patients with severe sepsis. N Engl J Med 1999; 340:207-14.
65 Hollenberg SM, Ahrens TS, Annane D, et al. Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update. Crit Care Med 2004; 32:1928-48.
66 Ninis N, Phillips C, Bailey L, et al. The role of healthcare delivery in the outcome of meningococcal disease in children: case-control study of fatal and non-fatal cases. BMJ 2005; 330:1475.
67 Neu J, Walker WA. Necrotizing enterocolitis. N Engl J Med 2011; 364:255-64.
68 Drop LJ, Laver MB. Low plasma ionized calcium and response to calcium therapy in critically ill man. Anesthesiology 1975; 43:300-6.
69 Friedman G, Silva E, Vincent JL. Has the mortality of septic shock changed with time? Crit Care Med 1998; 26:2078-86.
70 Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29:1303-10.
71 Watson RS, Carcillo JA. Scope and epidemiology of pediatric sepsis. Pediatr Crit Care Med 2005; 6(suppl 3):S3-5.
72 Fiser RT, West NK, Bush AJ, et al. Outcome of severe sepsis in pediatric oncology patients. Pediatr Crit Care Med 2005; 6:531-6.
73 Han YY, Carcillo JA, Dragotta MA, et al. Early reversal of pediatric-neonatal septic shock by community physicians is associated with improved outcome. Pediatrics 2003; 112:793-9.